2023 Fall Seminar Presentation Materials & ACPE Accreditation

Presentation Handouts & ACPE Accreditation

Title: Race-based Prescribing for Black and African American Individuals with High Blood Pressure: Is it Time for a Change?
Presentation
UAN: 0036-9999-23-229-L01-P/0036-9999-23-230-L01-T
Date & Time: 11/4/2023, 8:15 am
Speaker: Abby Frye, PharmD
Audience: RPh and CPT
Activity-Type: Application-based for RPh; Knowledge-based for CPT
Topic Designation: Disease State Management/Drug Therapy + Cultural Competence
Credit Hours: 1.0
RPh Learning Objectives:

1. Review the current hypertension treatment guidelines
2. Evaluate the impact of race-specific treatment recommendations for hypertension
3. Analyze the literature supporting race agnostic approach to hypertension management
4. Apply guidelines and literature to individualize treatment of hypertension

CPT Learning Objectives:

1. Review the current hypertension treatment guidelines
2. Evaluate the impact of race-specific treatment recommendations for hypertension
3. Discuss the literature supporting race agnostic approach to hypertension management

Title:  Statewide Formulary, Novel Practices with Reimbursement
Presentation
UAN: 0036-9999-23-221-L03-P/T
Date & Time: 11/4/2023, 9:35-10:35 am
Speakers: Lorinda Anderson, PharmD, BCPS; Amy Valdez, RPh
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Law Related to Pharmacy Practice
Credit Hours: 1.0
Learning Objectives:

1. Review the available statewide protocols in Oregon that allow pharmacists to prescribe under and what the overarching rules and regulations are that govern them
2. Explain how to engage with the Public Health and Pharmacy Formulary and Advisory Committee (PHPFAC) process from submitting ideas to serving as a subject matter expert
3. Identify the statewide protocols the PHPFAC is currently working on, and others that could be potentially developed 

Title: Prior Authorization & REMS (Technician Track)
Presentation Part 1
Presentation Part 2
UAN: 0036-9999-23-227-L04-T
Date & Time: 11/4/2023, 9:35-10:35 am
Speakers: Binh Tran, CPhT, B.S.; Allison Mishkin, CPhT
Audience: CPT
Activity-Type: Application-based
Topic Designation: Pharmacy Administration
Credit Hours: 1.0
Learning Objectives:

1. Apply the information provided from today to assist in Prior Authorization process
2. Solve or assist the pharmacist to solve Medication Prior Authorization rejections/issues
3. Use the information provided to help patients getting medications in a timely manner and minimize delay in Medication Treatment
4. Demonstrate the unique services provided at OHSU for medication Prior Authorization process
5. Practice on improving communication workflow to assist in Prior Authorization process
6. Define the FDA REMS Program and describe various components of a REMS drug
7. Recognize some of the drugs/types that are in the REMS program and when the REMS program is applicable
8. Recall the role(s) a pharmacy technician has in a pharmacy that dispenses REMS drugs

Title: New CDC Opioid Guidelines: What Changed and What Now for Pain?
Presentation
UAN: 0036-9999-23-222-L05-P/0036-9999-23-223-L05-T
Date & Time: 11/4/2023, 10:55-11:55 am
Speakers: Jessica Merlo, PharmD, BCACP
Audience: RPh and CPT
Activity-Type: RPh – Application-based; CPT – Knowledge-based
Topic Designation: Patient Safety
Credit Hours: 1.0
RPH Learning Objectives:

1. Recognize the impact, including unintentional consequences, of the 2016 CDC Opioid Prescribing Guideline
2. Explain the CDC’s rationale for updating the 2016 CDC Opioid Prescribing Guideline
3. Summarize major additions and changes to the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain
4. Apply the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain to a patient case scenario for a patient with pain

CPT Learning Objectives:

1. Recognize the impact, including unintentional consequences, of the 2016 CDC Opioid Prescribing Guideline
2. Explain the CDC’s rationale for updating the 2016 CDC Opioid Prescribing Guideline
3. Summarize major additions and changes to the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain

Title: Technician Career Ladder and Leadership (Technician Track)
Presentation Part 1
Presentation Part 2
UAN: 0036-9999-23-228-L99-T
Date & Time: 11/4/2023, 10:55-11:55 am
Speakers: Angela Koerner, PharmD, BCACP; Europa Babbini, CPhT; Kelli Johnson, CPhT-Adv
Audience: CPT
Activity-Type: Knowledge-based
Topic Designation: Additional Topic Areas
Credit Hours: 1.0
Learning Objectives: 

1. Describe process of a career ladder implementation in different pharmacy practice settings
2. Describe process of creating baseline and advance competencies to correspond with career ladder
3. Describe Technician Leadership opportunities

Title: Advances in the Management of Migraine
Presentation
UAN: 0036-9999-23-224-L01-P/T
Date & Time: 11/4/2023, 1:20-2:20 pm
Speakers: Kelsey Blom, PharmD, BCACP
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Disease State Management/Drug Therapy
Credit Hours: 1.0
RPh Learning Objectives:

1. Analyze the latest data on the efficacy, safety, and administration of recently approved therapies for the management of migraine
2. Recall important counseling points for use of the novel acute migraine medications
3. Recognize clinically significant drug interactions for newly approved migraine medications

CPT Learning Objectives:

1. Identify the names and therapeutic classes of newly approved migraine medications
2. Describe common side effects of newly approved migraine medications
3. Recall the strength, dosage forms, and routes of administration for newly approved migraine medications

1. Discuss principal indications for systemic hormone therapy (HT)
2. List HT contraindications, risks, and benefits
3. Optimize and individualize HT options depending on the patient’s clinical characteristics

CPT Learning Objectives:

1. Discuss principal indications for systemic hormone therapy (HT)
2. List HT contraindications, risks, and benefits

1. Define tobacco use disorder and how to incorporate the 5As into clinical practice
2. Review the types of tobacco products and electronic nicotine delivery systems (ENDS) and how this can affect a clinician’s approach to treatment
3. Identify evidence-based treatment approaches for tobacco use disorder
4. Explain the USPSTF 2021 updated recommendation regarding tobacco cessation treatment 

This activity has been planned and implemented in accordance with the policies of the Accreditation Council on Pharmacy Education (ACPE) through the joint providership of the Oregon State University College of Pharmacy and Oregon Society for Health-System Pharmacists (OSHP). Oregon State University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been approved for up to 5 hour(s) of ACPE accredited continuing pharmacy education.

Disclosures: None of the planners or presenters for this program have any financial relationships with ineligible companies to disclose. 

An ACPE Statement of Credit shall be issued to participants only after successful completion of the activity. Internet access is required for successful completion. Successful completion is defined as: 1) Attending, in its entirety, the CPE activity and receiving the unique activity Credit Code; 2) Participating in the pre-test administered by the presenter(s); 3) Completing the online activity evaluation and self-evaluation quiz located at:http://pharmacy.oregonstate.edu/ce within 60 days of program attendance. The Statement of Credit will be uploaded to the participant’s CPE Monitor automatically within 48 hours of successful activity completion. It is the participant’s responsibility to complete the online components (Step 3) within 60 days of program attendance. Credit will not be provided after 60 days.

Supplemental Resource Section

New CDC Opioid Guidelines: What Changed and What Now for Pain?

• Dr. Chou Video Recording
• Dr. Chou Handout